CLINICAL_TRIALS
research
· 2026-01-14
Clinical Trial Update: STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) [Phase 2]
Summary
Phase 2 trial evaluating estradiol for ER-positive advanced/metastatic breast cancer is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING